Dowell AC, Lancaster T, Bruton R, Ireland G, Bentley C, Sylla P, et al. Immunological imprinting of humoral immunity to SARS-CoV-2 in children. Nat Commun. 2023;14:3845.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang CQ, Vishwanath S, Carnell GW, Chan A, Heeney JL. Immune imprinting and next-generation coronavirus vaccines. Nat Microbiol. 2023;8:1971–85.

Article  CAS  PubMed  Google Scholar 

Reynolds CJ, Pade C, Gibbons JM, Otter AD, Lin KM, Muñoz Sandoval D, et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science. 2022;377:eabq1841.

Article  CAS  PubMed  Google Scholar 

Gao B, He L, Bao Y, Chen Y, Lu G, Zhang Y, et al. Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection. Cell Res. 2023;33:258–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ju B, Fan Q, Wang M, Liao X, Guo H, Wang H, et al. Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections. Nat Commun. 2022;13:7120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020;17:621–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Xu J, Jia R, Yi C, Gu W, Liu P, et al. Protective humoral immunity in SARS-CoV-2 infected pediatric patients. Cell Mol Immunol. 2020;17:768–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Chen Y, Cao K, Shen Y, Wu X, Yang Y, et al. Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection - an integrated account of virus pathogenicity and vaccination effectiveness. Natl Sci Rev. 2024;11:nwae011.

Article  PubMed  PubMed Central  Google Scholar 

Sun X, Yi C, Zhu Y, Ding L, Xia S, Chen X, et al. Neutralization mechanism of a human antibody with pancoronavirus reactivity including SARS-CoV-2. Nat Microbiol. 2022;7:1063–74.

Article  CAS  PubMed  Google Scholar 

Ling Z, Yi C, Sun X, Yang Z, Sun B. Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies. Sci China-Life Sci. 2023;66:658–78.

Article  CAS  PubMed  Google Scholar 

Pinto D, Sauer MM, Czudnochowski N, Low JS, Tortorici MA, Housley MP, et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021;373:1109–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, et al. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. 2021;6:eabg5021.

Article  PubMed  Google Scholar 

Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21:1107–18.

Article  CAS  PubMed  Google Scholar 

He B, Liu S, Xu M, Hu Y, Lv K, Wang Y, et al. Comparative global B-cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing. Emerg Microbes Infect. 2022;11:2007–20.

Article  CAS  PubMed  PubMed Central  Google Scholar